Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jun;41(6):1513-1519.
doi: 10.1007/s10072-019-04230-6. Epub 2020 Jan 20.

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)

Juan Ignacio Rojas  1   2 Marina Alonso Serena  3 Orlando Garcea  4 Liliana Patrucco  5 Adriana Carrá  6   7 Jorge Correale  8 Carlos Vrech  9 Agustín Pappolla  5 Jimena Miguez  5 María L Doldan  5   10 Facundo Silveira  5 Ricardo Alonso  4   11 Leila Cohen  4 Cecilia Pita  4 Berenice A Silva  4 Marcela Fiol  8 María I Gaitán  8 Mariano Marrodan  8 Laura Negrotto  8 María C Ysrraelit  8 Norma Deri  12 Geraldine Luetic  13 Alejandro Caride  14 Edgar Carnero Contentti  14 Pablo A Lopez  14 Juan Pablo Pettinicchi  14 Celeste Curbelo  6   15 Alejandra D Martinez  6 Judith D Steinberg  6 María E Balbuena  16 Verónica Tkachuk  16 Marcos Burgos  17 Eduardo Knorre  18 Felisa Leguizamon  18 Raúl Piedrabuena  19   20 Susana Del V Liwacki  19   21 Andrés G Barboza  22 Pedro Nofal  23 Gabriel Volman  24 Amelia Alvez Pinheiro  25 Javier Hryb  26 Dario Tavolini  27 Patricio A Blaya  28 Emanuel Silva  29 Jorge Blanche  30 Santiago Tizio  31 Fernando Caceres  32 María Laura Saladino  32 Gisela Zanga  33 María E Fracaro  34 Gustavo Sgrilli  35 Fátima Pagani Cassara  36 Guido Vazquez  7 Vladimiro Sinay  36 María Laura Menichini  37 Luciana Lazaro  11 Lorena M Cabrera  38   39 Santiago Bestoso  40 Pablo Divi  41 Miguel Jacobo  41 Eduardo Kohler  42 Matías Kohler  42 Diego Giunta  3 Carolina Mainella  43 Ruben Manzi  44 Marcela Parada Marcilla  45 Juan Pablo Viglione  46 Ivan Martos  47 Edgardo Reich  48 Gustavo Jose  49 Edgardo Cristiano  5   10 Nora Fernández Liguori  11   50 on behalf RelevarEM investigators
Affiliations
Observational Study

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)

Juan Ignacio Rojas et al. Neurol Sci. 2020 Jun.

Abstract

The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients included in RelevarEM (Clinical Trials registry number NCT03375177).

Methods: RelevarEM is a longitudinal, strictly observational MS and NMOSD registry in Argentina. Epidemiological and comorbidity data from MS and NMOSD patients were described and compared. For comorbidities, the Charlson comorbidity index (CCI) was used to calculate the burden at entry. CCI was stratified in 0 and ≥ 1 and described for the entire cohort.

Results: A total of 1588 and 75 MS and NMOSD patients (respectively) were included. For MS patients, the mean age was 42 ± 7 years, female sex 65.3%, mean EDSS 2, and mean disease duration 8 ± 6 years. In NMOSD, the mean age was 40 ± 7 years, female sex 78.7%, mean disease duration 5 ± 3.5 years, and mean EDSS 2.5. The most frequent MS phenotype was RRMS in 82.4%. In MS, the CCI was 0 in 85.8.2% while ≥ 1 was in 14.2% of patients. Regarding phenotype stratification, CCI ≥ 1 was 3.9% in CIS, 13.5% in RRMS, 28.7% in SPMS, and 17.4% in PPMS (p < 0.001 between groups). In NMOSD, the CCI was 0 in 64% while ≥ 1 was in 36%. The MS/NMOSD ratio found was 21/1.

Conclusions: This is the first analysis of the longitudinal Argentinean registry of MS and NMOSD describing and comparing conditions that contributes to provide reliable real-world data in the country.

Keywords: Epidemiology; Multiple sclerosis; Neuromyelitis optica spectrum disorder; Registry; RelevarEM.

PubMed Disclaimer

References

    1. Cristiano E, Patrucco L, Rojas JI (2008) A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol 15(12):1273–1278 - DOI
    1. Cristiano E, Rojas J, Romano M, Frider N, Machnicki G, Giunta D, Calegaro D, Corona T, Flores J, Gracia F, Macias-Islas M, Correale J (2013) The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review. Mult Scler 19(7):844–854 - DOI
    1. Kurtzke JF (2000) Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis. Neurol Sci 21(6):383–403 - DOI
    1. Kurtzke JF (2005) Epidemiology and etiology of multiple sclerosis. Phys Med Rehabil Clin N Am 16(2):327–349 - DOI
    1. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173 - DOI

Publication types

Associated data